Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,867	15,403	10,379	5,459	8,215	9,018
Market Cap Growth	48.41%	48.41%	90.12%	-33.55%	-8.90%	99.42%
Enterprise Value	8,486	14,978	9,810	5,150	7,936	8,417
Last Close Price	281.50	489.00	329.50	183.00	278.50	314.00
PE Ratio	51.75	89.46	113.04	296.26	1007.78	-
Forward PE	56.95	92.61	199.34	111.93	211.39	288.07
PS Ratio	10.78	18.73	17.37	13.15	31.80	50.14
PB Ratio	4.11	7.14	5.34	3.82	6.39	8.94
P/TBV Ratio	10.81	10.81	7.84	6.86	10.06	11.59
P/FCF Ratio	218.46	379.48	3172.09	564.50	-	-
P/OCF Ratio	138.41	138.41	224.23	195.98	-	-
EV/Sales Ratio	10.32	18.21	16.42	12.40	30.71	46.80
EV/EBITDA Ratio	56.73	100.14	515.41	387.15	-	-
EV/EBIT Ratio	96.04	169.52	1818.08	1156.32	-	-
EV/FCF Ratio	209.06	369.00	2998.27	532.54	-	-
Debt / Equity Ratio	0.02	0.02	0.02	0.01	0.00	0.01
Debt / EBITDA Ratio	0.23	0.23	1.06	0.51	-	-
Debt / FCF Ratio	0.84	0.84	9.61	1.03	-	-
Asset Turnover	0.36	0.36	0.30	0.25	0.19	0.20
Inventory Turnover	1.12	1.12	1.23	1.29	1.02	0.97
Quick Ratio	3.30	3.30	4.94	2.60	4.43	5.51
Current Ratio	4.58	4.58	6.15	3.47	5.24	6.41
Return on Equity (ROE)	8.39%	8.39%	5.44%	1.36%	0.71%	-5.51%
Return on Assets (ROA)	2.40%	2.40%	0.17%	0.17%	-0.87%	-3.09%
Return on Capital (ROIC)	2.65%	2.65%	0.20%	0.20%	-1.02%	-3.45%
Return on Capital Employed (ROCE)	4.00%	4.00%	0.30%	0.30%	-	-
Earnings Yield	1.94%	1.12%	0.89%	0.34%	0.10%	-0.48%
FCF Yield	0.46%	0.26%	0.03%	0.18%	-0.27%	-0.17%
Buyback Yield / Dilution	-5.73%	-5.73%	-1.39%	-2.04%	-6.49%	-1.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.